Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b/2a Clinical Study of AL58805 Combining With Other Anti-tumor Agents in Advanced, Metastatic GYN, STS or Breast Cancers

NCT07811232 is registered in ClinicalTrials.gov with Advenchen Pharmaceuticals, LLC. as lead sponsor.

NCT NCT07811232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07811232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b/2a Clinical Study of AL58805 Combining With Other Anti-tumor Agents in Advanced, Metastatic GYN, STS or Breast Cancers
Lead sponsor
Advenchen Pharmaceuticals, LLC.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2031
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, endometrial neoplasms, soft tissue sarcoma (sts)